Read Gavi's full statement, 01 Nov 2014: Pentavalent vaccine introductions represent historic milestone for immunisation in India
Although some parts of India have high vaccination coverage rates for diphtheria-tetanus-pertussis (DTP) vaccine, huge disparities exist. Switching to pentavalent will provide protection against a broader range of infectious diseases and is expected to increase immunisation coverage.
With 27 million children born in India each year, increasing immunisation coverage here should significantly reduce global child mortality rates.
Pentavalent vaccine is currently available free of charge in eight states, thanks to support from Gavi. There will be a two-phase approach to the national scale-up:
Phase 1: 12 additional states, starting with Rajasthan and Madhya Pradesh. By December two-thirds of infants born in India each year will have access to pentavalent vaccine;
Phase 2: The remaining 16 states will introduce the vaccine in April 2015.
From reviewing the supply chain and cold storage facilities to the training of staff, including community outreach workers, scaling up India's pentavalent programme has been an immense undertaking.
Watch these videos for three individual insights into India's successful preparation.
Pentavalent combines DTP with two additional vaccines that protect against hepatitis B (hepB) and Haemophilus influenzae type b (Hib) -- all in a single jab. In India there are as many as three million cases of Hib disease each year, resulting in the deaths of 72,000 children under five.
The 5-in-1 pentavalent vaccine is now available in all Gavi-supported countries at a record low price, but only 50% of the children are being reached.